Funding
The CAIRO5 study is supported by unrestricted scientific grants from Roche and Amgen. The funders had no role in the design, conduct and submission of the study, nor in the decision to submit the manuscript for publication. The authors had complete access to all study data that support this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
DISCLOSURE
Cornelis J.A. Punt has an advisory role for Nordic Pharma. Karen Bolhuis reports having an advisory role for Amgen. Johannes H.W. de Wilt has an unrestricted grant from Medtronic. Ulf P. Neumann reports presentations or contribution to research for Roche, Astra Zeneca, Merck AG, Sanofi, Grünenthal, Johnson & Johnson, and Astellas; this funding is not related to the current research. Marinde J.G. Bond, Babette I. Kuiper, Aysun Komurcu, Martinus J. van Amerongen, Thiery Chapelle, Cornelis H.C. Dejong, Marc R.W. Engelbrecht, Michael F. Gerhards, Dirk J. Grünhagen, Thomas van Gulik, John J. Hermans, Koert P. de Jong, Joost M. Klaase, Niels F.M. Kok, Wouter K.G. Leclercq, Mike S.L. Liem, Krijn P. van Lienden, I. Quintus Molenaar, Gijs A. Patijn, Arjen M. Rijken, Theo M. Ruers, Cornelis Verhoef, Geert Kazemier, Anne M. May, and Rutger-Jan Swijnenburg declare no potential conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Deceased: Cornelis H. C. Dejong
Rights and permissions
About this article
Cite this article
Bond, M.J.G., Kuiper, B.I., Bolhuis, K. et al. ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases—Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group. Ann Surg Oncol 30, 5388–5389 (2023). https://doi.org/10.1245/s10434-023-13595-0
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13595-0